Ten undescribed derivatives of lithocholic acid produced by biotransformation and their anti-neuroinflammatory
Chenhua Wang1, Gang Chen2, Wen Xu3
1Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Abstract:
Ten undescribed hydroxylated, acetylated, esterified and glycoside derivatives of lithocholic acid (LCA) were obtained through the biotransformation of Aspergillus minisclerotigenes, alongside four known compounds. Structural characterization employed integrated NMR spectroscopy, HR-ESI-MS, and X-ray crystallography. Biological evaluation identified compound 10 as a potent inhibitor of LPS-induced NO production in BV2 microglial cells (IC50 = 4.67 μM) and dose-dependently suppressed mRNA expression of IL-1β, TNF-α, iNOS, and COX-2. Furthermore, compound 10 promoted M2-polarization of LPS-activated microglia to attenuate neuroinflammation. Subsequent analysis demonstrated its induction of inflammatory autophagy in BV2 cells. These results suggested that biotransformation was an efficient strategy for structural diversification of LCA and discovery of potent anti-inflammatory leads.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
